1 Gastrointestinal OTC Drugs Market Overview 1.1 Product Overview and Scope of Gastrointestinal OTC Drugs 1.2 Gastrointestinal OTC Drugs Segment by Type 1.2.1 Global Gastrointestinal OTC Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Laxatives 1.2.3 Anti-Flatulents 1.2.4 H2-Antaginists 1.2.5 Anti-Diarrheals 1.2.6 PPIs 1.2.7 Anti-Emetics 1.2.8 Other 1.3 Gastrointestinal OTC Drugs Segment by Application 1.3.1 Global Gastrointestinal OTC Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Gastrointestinal OTC Drugs Market Size Estimates and Forecasts 1.4.1 Global Gastrointestinal OTC Drugs Revenue 2017-2028 1.4.2 Global Gastrointestinal OTC Drugs Sales 2017-2028 1.4.3 Gastrointestinal OTC Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Gastrointestinal OTC Drugs Market Competition by Manufacturers 2.1 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Gastrointestinal OTC Drugs Manufacturing Sites, Area Served, Product Type 2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends 2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue 2.5.3 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Gastrointestinal OTC Drugs Retrospective Market Scenario by Region 3.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country 3.3.1 North America Gastrointestinal OTC Drugs Sales by Country 3.3.2 North America Gastrointestinal OTC Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country 3.4.1 Europe Gastrointestinal OTC Drugs Sales by Country 3.4.2 Europe Gastrointestinal OTC Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region 3.5.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Gastrointestinal OTC Drugs Market Facts & Figures by Country 3.6.1 Latin America Gastrointestinal OTC Drugs Sales by Country 3.6.2 Latin America Gastrointestinal OTC Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country 3.7.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Gastrointestinal OTC Drugs Historic Market Analysis by Type 4.1 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2022) 4.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Gastrointestinal OTC Drugs Price by Type (2017-2022) 5 Global Gastrointestinal OTC Drugs Historic Market Analysis by Application 5.1 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2022) 5.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Gastrointestinal OTC Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Corporation Information 6.1.2 GlaxoSmithKline Description and Business Overview 6.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio 6.1.5 GlaxoSmithKline Recent Developments/Updates 6.2 Pfizer 6.2.1 Pfizer Corporation Information 6.2.2 Pfizer Description and Business Overview 6.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio 6.2.5 Pfizer Recent Developments/Updates 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson Corporation Information 6.3.2 Johnson & Johnson Description and Business Overview 6.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio 6.3.5 Johnson & Johnson Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Bayer Gastrointestinal OTC Drugs Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 Procter & Gamble 6.5.1 Procter & Gamble Corporation Information 6.5.2 Procter & Gamble Description and Business Overview 6.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio 6.5.5 Procter & Gamble Recent Developments/Updates 6.6 Perrigo 6.6.1 Perrigo Corporation Information 6.6.2 Perrigo Description and Business Overview 6.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio 6.6.5 Perrigo Recent Developments/Updates 6.7 Abbott 6.6.1 Abbott Corporation Information 6.6.2 Abbott Description and Business Overview 6.6.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Abbott Gastrointestinal OTC Drugs Product Portfolio 6.7.5 Abbott Recent Developments/Updates 6.8 Sanofi 6.8.1 Sanofi Corporation Information 6.8.2 Sanofi Description and Business Overview 6.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio 6.8.5 Sanofi Recent Developments/Updates 6.9 Teva Pharmaceutical 6.9.1 Teva Pharmaceutical Corporation Information 6.9.2 Teva Pharmaceutical Description and Business Overview 6.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio 6.9.5 Teva Pharmaceutical Recent Developments/Updates 6.10 Nestle 6.10.1 Nestle Corporation Information 6.10.2 Nestle Description and Business Overview 6.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio 6.10.5 Nestle Recent Developments/Updates 6.11 Boehringer Ingelheim 6.11.1 Boehringer Ingelheim Corporation Information 6.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Description and Business Overview 6.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio 6.11.5 Boehringer Ingelheim Recent Developments/Updates 6.12 Reckitt Benckiser 6.12.1 Reckitt Benckiser Corporation Information 6.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Description and Business Overview 6.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio 6.12.5 Reckitt Benckiser Recent Developments/Updates 6.13 Purdue Pharma 6.13.1 Purdue Pharma Corporation Information 6.13.2 Purdue Pharma Gastrointestinal OTC Drugs Description and Business Overview 6.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio 6.13.5 Purdue Pharma Recent Developments/Updates 7 Gastrointestinal OTC Drugs Manufacturing Cost Analysis 7.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs 7.4 Gastrointestinal OTC Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Gastrointestinal OTC Drugs Distributors List 8.3 Gastrointestinal OTC Drugs Customers 9 Gastrointestinal OTC Drugs Market Dynamics 9.1 Gastrointestinal OTC Drugs Industry Trends 9.2 Gastrointestinal OTC Drugs Market Drivers 9.3 Gastrointestinal OTC Drugs Market Challenges 9.4 Gastrointestinal OTC Drugs Market Restraints 10 Global Market Forecast 10.1 Gastrointestinal OTC Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Type (2023-2028) 10.2 Gastrointestinal OTC Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Application (2023-2028) 10.3 Gastrointestinal OTC Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Gastrointestinal OTC Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million) Table 2. Global Gastrointestinal OTC Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million) Table 3. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Gastrointestinal OTC Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Gastrointestinal OTC Drugs Sales (K Dose) of Key Manufacturers (2017-2022) Table 6. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Gastrointestinal OTC Drugs Average Price (USD/Dose) of Key Manufacturers (2017-2022) Table 10. Manufacturers Gastrointestinal OTC Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Gastrointestinal OTC Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Dose) Table 16. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022) Table 17. Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose) Table 20. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2022) Table 21. North America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose) Table 24. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Dose) Table 28. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose) Table 32. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose) Table 36. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose) Table 40. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2022) Table 41. Global Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Gastrointestinal OTC Drugs Revenue Share by Type (2017-2022) Table 43. Global Gastrointestinal OTC Drugs Price by Type (2017-2022) & (USD/Dose) Table 44. Global Gastrointestinal OTC Drugs Sales (K Dose) by Application (2017-2022) Table 45. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2022) Table 46. Global Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Gastrointestinal OTC Drugs Revenue Share by Application (2017-2022) Table 48. Global Gastrointestinal OTC Drugs Price by Application (2017-2022) & (USD/Dose) Table 49. GlaxoSmithKline Corporation Information Table 50. GlaxoSmithKline Description and Business Overview Table 51. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 52. GlaxoSmithKline Gastrointestinal OTC Drugs Product Table 53. GlaxoSmithKline Recent Developments/Updates Table 54. Pfizer Corporation Information Table 55. Pfizer Description and Business Overview Table 56. Pfizer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 57. Pfizer Gastrointestinal OTC Drugs Product Table 58. Pfizer Recent Developments/Updates Table 59. Johnson & Johnson Corporation Information Table 60. Johnson & Johnson Description and Business Overview Table 61. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 62. Johnson & Johnson Gastrointestinal OTC Drugs Product Table 63. Johnson & Johnson Recent Developments/Updates Table 64. Bayer Corporation Information Table 65. Bayer Description and Business Overview Table 66. Bayer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 67. Bayer Gastrointestinal OTC Drugs Product Table 68. Bayer Recent Developments/Updates Table 69. Procter & Gamble Corporation Information Table 70. Procter & Gamble Description and Business Overview Table 71. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 72. Procter & Gamble Gastrointestinal OTC Drugs Product Table 73. Procter & Gamble Recent Developments/Updates Table 74. Perrigo Corporation Information Table 75. Perrigo Description and Business Overview Table 76. Perrigo Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 77. Perrigo Gastrointestinal OTC Drugs Product Table 78. Perrigo Recent Developments/Updates Table 79. Abbott Corporation Information Table 80. Abbott Description and Business Overview Table 81. Abbott Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 82. Abbott Gastrointestinal OTC Drugs Product Table 83. Abbott Recent Developments/Updates Table 84. Sanofi Corporation Information Table 85. Sanofi Description and Business Overview Table 86. Sanofi Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 87. Sanofi Gastrointestinal OTC Drugs Product Table 88. Sanofi Recent Developments/Updates Table 89. Teva Pharmaceutical Corporation Information Table 90. Teva Pharmaceutical Description and Business Overview Table 91. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 92. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Table 93. Teva Pharmaceutical Recent Developments/Updates Table 94. Nestle Corporation Information Table 95. Nestle Description and Business Overview Table 96. Nestle Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 97. Nestle Gastrointestinal OTC Drugs Product Table 98. Nestle Recent Developments/Updates Table 99. Boehringer Ingelheim Corporation Information Table 100. Boehringer Ingelheim Description and Business Overview Table 101. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 102. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Table 103. Boehringer Ingelheim Recent Developments/Updates Table 104. Reckitt Benckiser Corporation Information Table 105. Reckitt Benckiser Description and Business Overview Table 106. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 107. Reckitt Benckiser Gastrointestinal OTC Drugs Product Table 108. Reckitt Benckiser Recent Developments/Updates Table 109. Purdue Pharma Corporation Information Table 110. Purdue Pharma Description and Business Overview Table 111. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 112. Purdue Pharma Gastrointestinal OTC Drugs Product Table 113. Purdue Pharma Recent Developments/Updates Table 114. Production Base and Market Concentration Rate of Raw Material Table 115. Key Suppliers of Raw Materials Table 116. Gastrointestinal OTC Drugs Distributors List Table 117. Gastrointestinal OTC Drugs Customers List Table 118. Gastrointestinal OTC Drugs Market Trends Table 119. Gastrointestinal OTC Drugs Market Drivers Table 120. Gastrointestinal OTC Drugs Market Challenges Table 121. Gastrointestinal OTC Drugs Market Restraints Table 122. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2023-2028) & (K Dose) Table 123. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2023-2028) Table 124. Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 125. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Type (2023-2028) Table 126. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2023-2028) & (K Dose) Table 127. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Application (2023-2028) Table 128. Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 129. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Application (2023-2028) Table 130. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2023-2028) & (K Dose) Table 131. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Region (2023-2028) Table 132. Global Gastrointestinal OTC Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 133. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Region (2023-2028) Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Gastrointestinal OTC Drugs Figure 2. Global Gastrointestinal OTC Drugs Market Share by Type in 2021 & 2028 Figure 3. Laxatives Product Picture Figure 4. Anti-Flatulents Product Picture Figure 5. H2-Antaginists Product Picture Figure 6. Anti-Diarrheals Product Picture Figure 7. PPIs Product Picture Figure 8. Anti-Emetics Product Picture Figure 9. Other Product Picture Figure 10. Global Gastrointestinal OTC Drugs Market Share by Application in 2021 & 2028 Figure 11. Hospital Pharmacies Figure 12. Retail Pharmacies Figure 13. Online Pharmacies Figure 14. Global Gastrointestinal OTC Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Gastrointestinal OTC Drugs Market Size (2017-2028) & (US$ Million) Figure 16. Global Gastrointestinal OTC Drugs Sales (2017-2028) & (K Dose) Figure 17. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2021 Figure 18. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2021 Figure 19. The Global 5 and 10 Largest Gastrointestinal OTC Drugs Players: Market Share by Revenue in 2021 Figure 20. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022) Figure 22. Global Gastrointestinal OTC Drugs Sales Market Share by Region in 2021 Figure 23. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022) Figure 24. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in 2021 Figure 25. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. France Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. India Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Saudi Arabia Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. UAE Gastrointestinal OTC Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 49. Sales Market Share of Gastrointestinal OTC Drugs by Type (2017-2022) Figure 50. Manufacturing Cost Structure of Gastrointestinal OTC Drugs Figure 51. Manufacturing Process Analysis of Gastrointestinal OTC Drugs Figure 52. Gastrointestinal OTC Drugs Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

GlaxoSmithKline Pfizer Johnson & Johnson Bayer Procter & Gamble Perrigo Abbott Sanofi Teva Pharmaceutical Nestle Boehringer Ingelheim Reckitt Benckiser Purdue Pharma